相关实验视频
Updated: Sep 13, 2025

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
513
萨科佩尼亚:对分子机制,诊断和新兴干预方法的当前见解
Siying Tu1, Xiaoyu Hao1, Shan Xu1
1Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China.
International journal of molecular sciences
|July 29, 2025
概括
老龄化人口面临的是肉症,其特点是肌肉缩和功能衰退. 本综述探讨了肉类症的研究.
科学领域:
- 老年学和肌肉生理学
背景情况:
- 全球人口老龄化带来了重大的公共卫生挑战.
- 标志着肌肉缩和功能衰退的萨尔科佩尼亚严重影响老年人的生活质量.
研究的目的:
- 为了提供一个全面的回顾最近在萨尔科佩尼亚研究的进步.
- 为了检查病理生理机制,诊断方法,和干预策略的萨尔科佩尼亚.
主要方法:
- 目前关于肉病的文献的综述.
- 分析关键的分子和细胞途径参与肌肉衰老.
- 评估临床翻译的挑战和机遇.
主要成果:
- 性激素 (,雌激素) 的下降是 anabolic 抵抗和与年龄相关的肌肉损失的关键驱动因素.
- 蛋白质代谢,线粒体功能障碍,炎症和神经肌肉结变性是关键的重点领域.
- 目前的研究突出了将发现转化为临床实践的机遇和挑战.
结论:
- 未来的方向包括精确的分类,早期检测和针对石症的个性化治疗策略.
- 强调跨学科合作,将管理转向积极主动,有针对性的干预措施.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K

